- Report
- March 2022
- 86 Pages
Global
From €3500EUR$4,109USD£3,078GBP
- Report
- October 2023
- 114 Pages
Global
From €3500EUR$4,109USD£3,078GBP
- Report
- October 2023
- 140 Pages
Global
From €3500EUR$4,109USD£3,078GBP
- Report
- September 2024
- 78 Pages
Global
From €3500EUR$4,109USD£3,078GBP
- Report
- December 2022
- 30 Pages
Global
From €1825EUR$2,000USD£1,551GBP
- Report
- September 2022
- 104 Pages
Global
From €1825EUR$2,000USD£1,551GBP
- Report
- April 2022
- 169 Pages
Global
From €1825EUR$2,000USD£1,551GBP
- Book
- November 2019
- 278 Pages
From €118EUR$129USD£100GBP
- Report
- January 2025
- 132 Pages
Global
From €867EUR$950USD£737GBP
- Report
- August 2024
- 93 Pages
China
From €1643EUR$1,800USD£1,396GBP
- Report
- March 2024
- 132 Pages
Global
From €867EUR$950USD£737GBP
- Report
- October 2024
- 240 Pages
Global
From €1696EUR$1,859USD£1,441GBP
€2423EUR$2,655USD£2,059GBP
- Report
- July 2024
- 326 Pages
Global
From €1558EUR$1,707USD£1,324GBP
€2226EUR$2,439USD£1,891GBP
- Report
- April 2022
- 210 Pages
Global
From €2208EUR$2,419USD£1,876GBP
€3154EUR$3,456USD£2,680GBP
- Book
- August 2022
- 560 Pages
The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more
